This site uses cookies to help us give you the best experience on our website. For more details about these cookies, read our
Privacy policy
Hide this
Member Zone
Advanced search
Home
About us
Industry info
Our work
Media centre
Contact
Site map
Page Image
Page Content
ABPI
Accessibility
General terms and conditions for use of the ABPI's websites
Advanced search
Commercial
About us
Our objectives
Our organisation
ABPI Board of Management
Membership
Full membership
Full Member list
Research Affiliate membership
Research Affiliate Member list
General Affiliate membership
General Affiliate Member list
Frequently asked questions about membership
How we work
Working with our members
Collaborative working
Working at the ABPI
Current job opportunities
Work placements
FAQ
ABPI Exam
Industry info
Industry achievements
The pharmaceutical industry in the UK
Timeline of medicines research
1950–1959
1960–1969
1970–1979
1980–1989
1990–1999
2000 onwards
Knowledge hub
A global industry
Global pharmaceutical industry and market
Global pharmaceutical trade
Top 100 prescription medicines
Top world pharmaceutical corporations
Pharmaceuticals and the UK economy
The pharmaceutical industry and market in the UK
Employment in the pharmaceutical industry in the UK
Pharmaceutical trade in the UK
The pharmaceutical industry's manufacturing base in the UK
Leading pharmaceutical corporations’ UK market share
Top products in the UK
Value of the pharmaceutical industry in the UK
Monthly Annual Total (MAT) trade balance
Research and development: Innovation and investment
Research and development funding
Research and development expenditure
The development of new medicines
Industry/university collaborations in the UK
Medicines and the NHS
NHS expenditure in the UK
Community prescribing in the UK
Prescriptions in the UK, by therapeutic area
NICE decisions
Major diseases in the UK
Future
A flexible drug development process
Increased collaboration
Value and outcomes evaluation in trial design
Personalised medicines
Corporate responsibility
Environmental impact
Global access to medicines
Community support
Developing new medicines
Animals and medicines research
Glossary
Links
Our work
ABPI news
ABPI response to General Medical Council (GMC) consultation
2013
Looking ahead to 2013
Joint ABPI/ALLIANCE seminar on chronic back pain
ABPI Chief Executive takes part in Today programme interview on clinical trial data
Driving the clinical trial transparency agenda forward
Flaws in the QALY show why we need a broader definition of value
ABPI NHS Partnership Manager to take part in free webinar on joint working in the NHS
Prescribing guidance is victory for common sense and patient safety
New guidance on UK data protection in pharmacovigilance
Championing a UK success story – making growth sustainable
ABPI Conference 2013 – registration now open
Free webinar with PMCPA Director on the ABPI code and digital
Stephen Whitehead and Ben Goldacre debate
Perceptions count: why Britain must be seen as being open for business
ABPI publishes guidance for companies on pharmacovigilance for company employees
Helping the NHS to meet financial challenges – the role of the pharmaceutical industry
Tackling the growing issue of antimicrobial resistance
Fighting the growing threat of counterfeit medicines
ABPI supports launch of NICE Implementation Collaborative Concordat
Workshop on clinical trial transparency to be hosted by the ABPI
Expenditure, efficiency and the interests of patients
2012
A perfect storm?
Providing good value for money to the NHS
Working together to solve medicine supply shortages
David Willetts commits to NHS adoption of new ideas at parliamentary reception on innovation
The importance of end of life medicines
New accreditation scheme tackles bioscience skills gap
Interview with ABPI Chief Executive discusses future of pharma
UK Government shows support for industry in 2012 Budget
Promoting positive collaboration to improve patient health
ABPI Cymru Wales publishes spring bulletin
ABPI President and ESHLSG Co-Chair talks about new collaboration guidance
Stephen Whitehead's speech from the ABPI Annual Conference 2012 (abridged version)
Deepak Khanna's speech from the ABPI Annual Conference Dinner 2012
Deepak Khanna's closing speech from the ABPI Annual Conference 2012
Stephen Whitehead's speech from the ABPI Annual Conference Dinner 2012
Conference success hails new ABPI President
Investing in innovation
Earl Howe's speech at the 2012 ABPI Annual Conference dinner
ABPI launches new Joint Working tool
2011
ABPI statement: Former ABPI President Nigel Brooksby appointed to Cogent SSC Board
Welcome to our new ABPI website
Value based pricing/Cancer Drugs Fund
A new approach to collaboration
Getting the relationship right
Does Real World data matter?
Affordability of cancer treatments
ABPI holds successful innovation in healthcare conference
Code Awareness Week 2011
One day ABPI Masterclass “PPRS – more than just the numbers”
Patient access to innovative medicines – new concerns, same issues, the work continues
New pharmacovigilance (drug safety) guidance
One day ABPI Masterclass “PPRS – in practice”
Nigel Brooksby: 'Clinical Research - Innovation: Now is the right time to get it right for skills'
All Wales Medicines Strategy Group (AWMSG) Masterclass
Times Educational Supplement shines light on science
Patients are the priority - wholesaler dealer license numbers must be cut
Real World data guidance published today
The problem of counterfeit medicines
ABPI, CBI and public sector leaders meet to discuss the future of the pharmaceutical industry
2010
New reports highlight the valuable contribution of the pharmaceutical industry in the UK
ABPI November 2010 Conference
Research, medical and innovation
Driving innovation
Technical matters
Counterfeiting
Early research and development
Clinical research and late phase clinical trials
Regulatory affairs
Drug safety
Education and skills
Value and access
Cancer Drugs Fund/Value based pricing
Health Technology Assessment (HTA)
QIPP and Joint Working
Working with the NHS
UK Pharmascan
Partnership groups
Diabetes group
Orphan Medicines Industry Group
Pharmaceutical Oncology Initiative (POI)
The Pharmaceutical Mental Health Initiative
Pharmaceutical Ophthalmology Initiative (POPI)
Commercial
Medicines supply chain – working towards a solution
Understanding the PPRS
Decisions of the 2009 Pharmaceutical Price Regulation Scheme Dispute Resolution Panel
Reputation
Strategy
Annual review
Manifesto
Strategic Plan
Policy and parliamentary work
Cancer Drugs Fund
Commissioning
EU Framework Programme
Prescribing and managing medicines and devices (General Medical Council)
Health White Paper
Immigration consultations
National Curriculum Review
NHS Outcomes Framework
Skills for Sustainable Growth
Value-based pricing
Health Select Committee inquiry into public expenditure
Research and Development (R&D) Tax Credits consultation
Transposition of European directive 2010/63/EU - protection of animals used for scientific purposes
Higher Education White Paper
Briefing – Local formularies in the NHS
Briefing – Tenders and brokerage in the NHS
National Assembly for Wales – Inquiry into the contribution of community pharmacy
Patient Organisation Forum
ABPI library
Annual reviews and strategic plans
ABPI Annual Report 2009–2010
ABPI Manifesto: Prescription for innovation
ABPI 2010 Strategic Plan
ABPI 3 Year Strategic Plan
Prescription for innovation – Northern Ireland
Prescription for innovation – Wales
ABPI Scotland: Medicines for Scottish life
ABPI Annual Review 2010/11
Annual review 2011/12
Annual review 2012
Guidelines
Cancer commissioning toolkit
Guidelines for phase 1 clinical trials (2007 edition)
First in human studies
ABPI guidelines for the secondary use of data for medical research purposes
Model clinical trial agreement clinical guidelines
Model clinical trial agreement – England
Model clinical trial agreement – Wales
Model clinical trial agreement – Northern Ireland
Model clinical trial agreement – Scotland
Clinical trial compensation guidelines
Introduction to the work of research ethics committees in the United Kingdom- 3rd Edition
Non-rodent selection in pharmaceutical toxicology
Indemnity form – England & Wales
Indemnity form – Scotland
Batch recall of pharmaceutical products
Guidelines on the selection, use and maintenance of respiratory protective equipment in the pharmaceutical industry
ABPI guidance notes on joint working between pharmaceutical companies and the NHS and others for the benefit of patients
Notification and management of medicines shortages, best practice guidelines
Ensuring best practice in the notifications of product discontinuation: Best practice guidelines
Best practice model for the disclosure of results and transparent information on clinical trials
Industry information
Did you know? Facts and figures about the pharmaceutical industry in the UK
The pharmaceutical industry’s contribution to improving UK health outcomes and productivity
The pharmaceutical industry’s contribution to the UK economy and beyond
Understanding the 2009 PPRS
The changing shape of academic collaborations with the pharmaceutical industry
Skills needs for biomedical research
Global health and the pharmaceutical industry
An insight into careers for doctors with the UK pharmaceutical industry
Contribution of pharma-related businesses to the Scottish economy
In vivo sciences in the UK: sustaining the supply of skills in the 21st century
ABPI joint statement supporting changes to the Code of Practice
ABPI Cymru Wales joint statement supporting changes to the Code of Practice
At work with science website flyer
ABPI Careers website flyer
Pharmacovigilance and the Internet: A Call for Change
Research, Medical and Innovation leaflet
The vision for Real World Data - harnessing the opportunities in the UK
Health and the use of medicines in primary care in Wales
Time to flourish – Inside innovation: the medicine development process
Enriching research, training scientists
Medical and disease area information
Pharmaceutical Oncology Initiative brochure
Report of a survey of service provision for patients with RA and associated conditions
Animals and medicines research
Finding the balance – Benefits and risks of medical treatment – A paper and consultation document
What are the prospects for a golden era in vaccines?
Cancer, health and the health service in Wales
Current issues in paediatric clinical trials
Current issues in clinical trials
The diabetes information jigsaw
The cancer information maze
Animal research and human medicine
A–Z of medicines research
Chemotherapy Planning Oncology Resource Tool
Information provision in diabetes - 'Good Practice Forum' report
Skincare conditions in Scotland: what the health professionals think
ABPI Resources for schools website flyer
The stratification of disease for personalised medicines
Better vision for all
Posters
Safe use of Medicines
The periodic table of elements
Life enhancing careers – careers for scientists in the pharmaceutical industry
Biotechnology
Cloning
Genetic Engineering
Human Genome Project
Polymerase Chain Reaction (PCR)
Stem Cell Research
Careers
Schools
Media centre
ABPI on social media
News releases and statements
2013
New Innovation Scorecard shows the extent of regional variation in the NHS
ABPI responds to announcement of a new fund in Scotland for people with rare diseases
ABPI statement on alltrials.net
ABPI statement on antimicrobial medicines
ABPI comment on the ECHOUTCOME project
ABPI statement on pricing negotiations
Consultation launched to promote greater transparency between healthcare professionals and industry
ABPI and PM Society cement ties with joint working agreement
ABPI response to GMC's new prescribing guidance
ABPI response to Guardian article on antimicrobial resistance
ABPI response to questions from Sense about Science about alltrials.net
Engagement with Dr Ben Goldacre
ABPI response to Lancet editorial on collaboration guidance
ABPI membership continues to grow
ABPI statement on GSK signing up to the Alltrials campaign
ABPI response to Times article on patents
ABPI's relationship with Luther Pendragon
Steve Oldfield appointed to influential Medicines Access Group
ABPI Scotland welcomes investment in drug discovery
Stakeholder engagement on value-based pricing
2012
Pharmaceutical industry leaders recognised in New Year Honours list
New look for science resources website will help teachers and students
ABPI response to AstraZeneca restructuring initiatives
ABPI hires Luther Pendragon for public affairs support
Innovation and commercial success
Department of Health report shows UK medicines are good value for money
ABPI welcomes UK plan for rare disease
Can we afford innovation in medicine?
ABPI appoints Catherine Meaden as Head of Policy and Public Affairs
Transporting animals for research purposes: the importance of high quality care and welfare
ABPI response to Budget 2012
ABPI welcomes further investment in the UK
Healthcare community agree on principles for working together to improve patient health
The pharmaceutical industry and education: the benefits of partnership
ABPI launches Regional Partnership team to improve patient health
Is saving money more important than saving lives?
New ABPI President appointed
ABPI develops Medical and Innovation capability
ABPI response to the publication of the APPG report on supply shortages
ABPI launches guide to set up joint working projects
2011
Statement – Response to Government’s Health Bill
Cancer Drugs Fund - both an opportunity and a challenge
News release – Best practice guidance on medicine supply - a step in the right direction
News release – Leading healthcare figures pledge support for new ways of working with pharmaceutical industry
News release – Stark regional variation in patient access to NICE-approved drugs
News release – ABPI supports broader definition of value for any future value-based pricing
News release – Stephen Whitehead appointed new Chief Executive of ABPI
News release – Embracing innovation will help deliver better patient care
News release – ABPI and BIA to co-locate in new offices
News release – ABPI produces guidance to help industry demonstrate value for its products
News release – Value-based pricing must be part of a package of measures if it is to increase patient access to branded medicines
News release – Earlier Access Scheme
Statement – Response to European Parliament vote on Falsified Medicines Directive
Statement – Response to 2011 budget and growth review announcements
Statement – Letter in response to Independent on Sunday article, 3 July 2011
Statement – Letter in response to Independent on Sunday article, 3 July 2011
Statement – Letter in response to Observer article, 3 July 2011
Statement – Letter in response to Scottish Daily Mail article, 9 July 2011
Statement – Reaction to Government response on value based pricing consultation
Statement – Response to Pharmaceutical Journal comment by Graham Phillips et al, Wednesday 20 July 2011
2010
ABPI appoints new Director of Corporate Communications
ABPI appoints new Membership Engagement Account Director
Generic substitution: patient safety comes first
Alison Clough becomes Commercial and Communications Director at ABPI
First UK medicines reach Haiti
"The power of partnerships" highlighted by Office for Life Sciences Report
New ABPI President Announced
ABPI appoints new Head of Government Affairs
Life sciences sector will welcome Minister for Life Sciences
ABPI Builds Scottish Team with Key Appointment
ABPI appoints Director of value and access
Awards for NHS - Industry joint working projects
Patrick Walker appointed to Pharmaceutical Price Regulation Scheme (PPRS) Dispute Resolution Panel
ABPI appoints new Head of Commercial Affairs
New Study reveals UK patients are less likely to receive innovative medicines
Urgent action needed to ensure UK patients get their medicines
Interim fund an “Important First Step” to help UK cancer patients
2009
Prices of medicines hit all-time low
ABPI welcomes patent box
ABPI welcomes new bioscience campus
ABPI welcomes Brown’s commitment to innovation and cancer care
Survey emphasises need for OLS plans to become reality
Call to action to boost vital medicines research
Use of NICE- appraised medicines in the NHS: ABPI response
Life sciences sector applauds Office for Life Sciences “Life Sciences Blueprint” as a major milestone towards securing the future of the UK industry
ABPI appoints director of value
Health secretary praises the work of the UK pharmaceutical industry
ABPI appoints new medical and innovation director
Alan Johnson to speak at key pharma event
ABPI publishes new guidance on joint working with the NHS
Roche reinstated to ABPI membership
ABPI welcomes RCP report
ABPI welcomes fall in animal rights attacks
2008
ABPI Code Introduced New Requirements For Working With Health Professionals And Patient Groups
Judgement Will Work For Benefit Of Patients, Says ABPI
"Industry At Crossroads" says Outgoing ABPI President
Threat To Pharmaceutical Industry Support for University Research
Vaccines 'Golden Era' Is Under Threat
Make Alzheimer's One Of Top Research Priorities, Says Public
Top Awards For Innovative Pharmacists
Bellwether Industry’s Confidence In UK Slumps – ABPI/CBI Survey
Innovation Must Be Practised As Well As Preached, Says ABPI
Terry Pratchett: UK At Forefront Of Alzheimer's Research
Budget: ABPI Welcomes Boost For Science In Schools
Government Response To Select Committee Inquiry Into NICE: ABPI Comment
New Joint Working Scheme Follows On From ‘Toolkit’ Launch
Proposed Legislation On Clinical Trials: ABPI Statement
UK Takes Lead In Researching Medicines For Breathing Disorders
ABPI Hails Opportunity To Consolidate Pharmacy Representation
ABPI Exams Continue To Improve Industry Standards
Patients Will Not Benefit From Select Committee Recommendations On NICE, Says ABPI
PPRS Renegotiation: Joint ABPI/DH Statement
Relaunched Website Better For Teachers And Students
2007
UK Backing For Plan To Put Europe At Forefront Of Medicines Research
Treatment prospects for Multiple Sclerosis will improve
New research reveals people with neurological conditions are being left in an information void and not receiving adequate care
OFT Study Into Medicines Distribution: ABPI Comment
New ABPI President Named
More Action Needed To Help Britain Beat Cancer
OXFAM Report: ABPI Statement
ABPI To Revise Code Of Practice
Welsh Deputy First Minister To Speak At ABPI Conference
More Companies Join ABPI
New Science Diploma Warmly Welcomed By Pharmaceutical Industry
Timely Emphasis On Science Skills In Sainsbury Report
Welcome for Darzi Report From UK-Based Pharmaceutical Industry
Action Plan Proposed To Boost Students’ In Vivo Skills
UK-Wide Innovation In Pharmacy Recognised By Awards
New Clinical Trial Guidelines Reflect Northwick Park Lessons
Alzheimer's Medicines Judicial Review: ABPI Statement
Negotiations Over New PPRS: ABPI Statement
Animal Extremist Activity Drops To New Low
New publication spells out pharmaceutical industry commitment to developing world
2006
Primate research done only when absolutely necessary, ABPI says
Revised guidelines on Phase 1 trials to follow Duff Report
ABPI Welcomes 'Shot in the Arm' For Health Research From Cooksey Review
ABPI hails industry's growing social responsibility at awards ceremony
NICE Decisions ‘Should Be More Transparent’
UK 'short-changes' patients over getting top quality healthcare – ABPI manifesto calls for action
UK Countries' different assessment systems delay patients getting right medicines
ABPI condemns NICE'S decision on alzheimer's medicines
Another new member for ABPI
Company suspended from ABPI membership over breaches of code
Journalists give vote of approval to ABPI press relations
Trust vital for future of NHS and patient care, says ABPI President
ABPI welcomes new members
Pharmaceutical Industry Backs CBI Call On Science Teaching
New Board to co-ordinate government health research funding proposed by ABPI
Scottish Pharmacists dominate ABPI awards
Pharmaceuticals contribute over £800 million to the Scottish economy
‘Sea Change’ In Level Of Attacks By Animal Extremists
New treatments for COPD in pipeline
Long-term plans needed to tackle world health crisis, Government told.
2005
Asian tsunami disaster: relief aid by pharmaceutical companies
Global clinical trial register gets UK pharmaceutical industry backing
ABPI makes key recommendations to House of Commons Select Committee inquiry
Animal extremists' intimidation scares off companies suppliers
Pharmaceutical Industry Backs ‘3Rs’ Centre With Sponsorship Of New Post
Pharmaceutical Industry Applauds Determination To End Animal Extremism
Pharmaceutical industry backs '3R's' centre with sponsorship of new post
Education system failing to provide top scientists needed by research - based pharmaceutical industry
ABPI launches Paediatric trials guide
NICE's draft recommendations on Alzheimer's Medicines are blow to patients and to future research, says ABPI
Response to Health Select Committee report 'The Influence of the Pharmaceutical Industry'
Warning from ABPI as key Pharmaceutical Industry Indicators slip
Proposals to reverse science graduate decline welcomed by ABPI
Passage of Crime Bill will protect UK science, say ABPI
Guide to PPRS published by ABPI
Code review attracts strong response
Lecturer post for ABPI Commercial Affairs Director
ABPI welcomes Nuffield animals in science report
Doctors' and Pharmaceutical companies' framework welcomed
More medicines being developed for breast cancer than ever, report shows
2004
Wholehearted welcome for judgement in Parallel Trade Case
New directory will aid journalists, says ABPI
Parallel trade strikes at industry's ability to invest in search for new medicines, seminar told
Pharmaceutical company's investment 'is vote of confidence' in UK
Cambridge primate facility decision: ABPI statement
Professor Jones appointed to WHO commission
NHS spends far less on innovative medicine than people believe, survey shows
£76 million research collaboration welcomed
ABPI welcomes government's commitement to innovation
UK-based Pharmaceutical industry challenges government to help create more young scientists
Huge progress in heart disease treatment applauded by ABPI
ABPI applauds government increase in targeted research funding
ABPI regrets delayed european legislation for children's medicines
Recruiting patients for clinical trials remains a challenge
NICE and ABPI make progress on release of confidential data
Pharmaceutical Industry trade surplus higher than expected
Government's innovative plans threatened by lack of qualified R&D staff
New animal research centre gets warm welcome from pharmaceutical industry
Childhood leukaemia deaths set to drop further as new medicines are developed, report says
Handbook provides quick reference on healthcare
2003
New directory will aid journalists
Pharmaceutical Industry is leader in innovation
Pharmaceutical Industry welcomes strong endorsement of partnership working with NHS Scotland
Welcome for increased spending on public healthcare
New ABPI President named
Pharmaceutical Industry works on developing more medicines for women, children and the elderly
Trade Balance in medicines shows big 6 month jump
Scientific breakthrough leads to new medicines for skin disease
Patient information key to achieving better health outcomes
ABPI Scotland welcomes moves to end postcode prescribing, patients deserve quick access to the most appropriate medicines.
Welcome for Cambridge Laboratory decision
Pharmaceutical Industry welcomes Bioscience report
New Medicines key to success of industry and NHS, says ABPI
ABPI welcomes new report on Clinical Research
ABPI welcomes Government plans to end postcode in cancer, but warns problem is wider
ABPI Cymru Wales office opens
Pharmaceutical Industry continues to lead UK R&D Investment
ABPI welcomes High Court injunction on harrassment
Medicines given Scottish public's vote of confidence but patients want more information
Executive biographies
Alison Clough
Andrew Powrie-Smith
Carol Wilson
Dr Richard Greville
Stephen Whitehead
Geoff Bailey
Carol Blount
Samantha Ogden
Deepak Khanna
Dr Bina Rawal
Colette Goldrick
Paul Catchpole
Catherine Meaden
Contact
ABPI Cymru Wales
ABPI Northern Ireland
ABPI Scotland
Industry groups
Pharmaceutical Industry Alliance (PIA)
Scottish Cardiovascular Industry Group (SCVIG)
Scottish Sexual Health Industry Group (SSHIG)
Scottish Cancer Industry Group (SCIG)
Share this page
Print this page
Get in touch
Please choose the subject of your enquiry from the list below:
Please select
ABPI Code of Practice
ABPI Exam (inc. certificates)
Careers in the pharmaceutical industry
Job vacancies at the ABPI
Membership
Press enquiries
Publications
School/college education
University education
Other
Enter the above code here:
Can't read? Try different words.
Submit
I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.